Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors

Hailin Zhang, Qiao Li, Xuan Yao, Bo Wang, Yawen Pan, Guoqiang Yuan

Open source

DOI
10.21037/tcr-2026-1700
Published
2026-10
Container
Translational Cancer Research
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-1700,
  title = {Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors},
  author = {Hailin Zhang and Qiao Li and Xuan Yao and Bo Wang and Yawen Pan and Guoqiang Yuan},
  year = {2026},
  journal = {Translational Cancer Research},
  doi = {10.21037/tcr-2026-1700},
  url = {https://doi.org/10.21037/tcr-2026-1700}
}

RIS

TY  - JOUR
TI  - Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors
AU  - Hailin Zhang
AU  - Qiao Li
AU  - Xuan Yao
AU  - Bo Wang
AU  - Yawen Pan
AU  - Guoqiang Yuan
PY  - 2026
JO  - Translational Cancer Research
DO  - 10.21037/tcr-2026-1700
UR  - https://doi.org/10.21037/tcr-2026-1700
ER  - 

APA

Zhang, H., Li, Q., Yao, X., Wang, B., Pan, Y., & Yuan, G. (2026). Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors. Translational Cancer Research. https://doi.org/10.21037/tcr-2026-1700

Source records